160
Participants
Start Date
July 13, 2022
Primary Completion Date
February 28, 2023
Study Completion Date
February 28, 2023
cytisinicline
film-coated oral tablets containing 3 mg cytisinicline
Placebo
film-coated oral tablets containing matched placebo
Behavioral support
Behavioral support sessions by a qualified study site staff member will be participant-driven and will include direct engagement with the participant about their attempt to quit vaping. Each session will last approximately 10 minutes.
Rochester Clinical Research, Inc, Rochester
Costal Carolina Research Center, North Charleston
Alliance for Multispecialty Research, LLC, Knoxville
Alliance for Multispecialty Research, LLC, Lexington
Massachusetts General Hospital - Clinical Genetic Research Facility, Boston
Lead Sponsor
Achieve Life Sciences
INDUSTRY